研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2024 年的期刊文章 · 第 14 页
共 1515 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2024-06-15 到 2024-06-04。
按期刊、按主题看 →
SiM Spatial & Time Series · 发表于 2024-06-15
Ziyue Liu, Wensheng Guo
摘要
In this paper, we aim to both borrow information from existing units and incorporate the target unit's history data in time series forecasting. We consider a situation when we have time series data from multiple units that share similar patterns when aligned in terms of an internal time. The internal time is defined as an index according to evolving features of interest. When mapped back to the calendar time, these time series can span different time intervals that can include the future calendar time of the targeted unit, over which we can borrow the information from other units in forecasting the targeted unit. We first build a hierarchical state space model for the multiple time series data in terms of the internal time, where the shared components capture the similarities among different units while allowing for unit‐specific deviations. A conditional state space model is then constructed to incorporate the information of existing units as the prior information in forecasting the targeted unit. By running the Kalman filtering based on the conditional state space model on the targeted unit, we incorporate both the information from the other units and the history of the targeted unit. The forecasts are then transformed from internal time back into calendar time for ease of interpretation. A simulation study is conducted to evaluate the finite sample performance. Forecasting state‐level new COVID‐19 cases in United States is used for illustration.
SiM Other · 发表于 2024-06-15
Paddy Farrington, Solène Lellinger
摘要
Data on retrospective compensation claims for injuries caused by pharmaceutical drugs are prone to selection and reporting biases. Nevertheless, this case study of the antidiabetic drug benfluorex shows that such data can be used to estimate the cumulative incidence of drug‐related injury, and to provide insights into its epidemiology. To this end, we develop a modelling framework for under‐reporting of retrospective claims for compensation arising from drug damage. The model involves a longitudinal component related to attrition of cases over time, and a cross‐sectional component related to incomplete reporting. We apply this model to cardiac valve surgery necessitated by exposure to benfluorex. Benfluorex was marketed in France between 1976 and 2009, when it was withdrawn because it caused valvular heart disease. A scandal erupted in 2010 over the scale of the damage caused by the drug. Since then, no further estimates of cumulative incidence have been published, though thousands of claims for compensation have been processed. The analysis combines compensation claims data and sociological survey data on benfluorex users, together with data on benfluorex sales and duration of treatment. We find a threshold of toxicity at about 6 months' exposure, and that at least 1690 individuals (95% CI 1290 to 2320) needed heart surgery to replace or repair valves damaged by exposure to benfluorex in France: a cumulative incidence of 3.68 per 10,000 (95% CI 2.68 to 5.34) benfluorex users or 3.22 per 10,000 (95% CI 2.48 to 4.39) person‐years at risk above the exposure threshold. While these findings are tentative, they are consistent with those obtained previously using very different methods.
Biometrika Networks & Graphs Spatial & Time Series Optimization & Learning Theory · 发表于 2024-06-14
Yichen Zhu, Michele Peruzzi, Cheng Li, David B Dunson
摘要
In geostatistical problems with massive sample size, Gaussian processes can be approximated using sparse directed acyclic graphs to achieve scalable O(n) computational complexity. In these models, data at each location are typically assumed conditionally dependent on a small set of parents that usually include a subset of the nearest neighbours. These methodologies often exhibit excellent empirical performance, but the lack of theoretical validation leads to unclear guidance in specifying the underlying graphical model and sensitivity to graph choice. We address these issues by introducing radial-neighbour Gaussian processes, a class of Gaussian processes based on directed acyclic graphs in which directed edges connect every location to all of its neighbours within a predetermined radius. We prove that any radial-neighbour Gaussian process can accurately approximate the corresponding unrestricted Gaussian process in the Wasserstein-2 distance, with an error rate determined by the approximation radius, the spatial covariance function and the spatial dispersion of samples. We offer further empirical validation of our approach via applications on simulated and real-world data, showing excellent performance in both prior and posterior approximations to the original Gaussian process.
Biometrika Networks & Graphs High-Dimensional · 发表于 2024-06-14
S Højsgaard, S Lauritzen
摘要
In Gaussian graphical models, the likelihood equations must typically be solved iteratively. This paper investigates two algorithms: a version of iterative proportional scaling, which avoids inversion of large matrices, and an algorithm based on convex duality and operating on the covariance matrix by neighbourhood coordinate descent, which corresponds to the graphical lasso with zero penalty. For large, sparse graphs, the iterative proportional scaling algorithm appears feasible and has simple convergence properties. The algorithm based on neighbourhood coordinate descent is extremely fast and less dependent on sparsity, but needs a positive-definite starting value to converge. We provide an algorithm for finding such a starting value for graphs with low colouring number. As a consequence, we also obtain a simplified proof of existence of the maximum likelihood estimator in such cases.
Biometrika Causal Inference Nonparametric & Semiparametric · 发表于 2024-06-14
Yihui He, Fang Han
摘要
This paper re-examines the work of Abadie & Imbens (2016) on propensity score matching for average treatment effect estimation. We explore the asymptotic behaviour of these estimators when the number of nearest neighbours, M, grows with the sample size. It is shown, while not surprising, but technically nontrivial, that the modified estimators can improve upon the original fixed M-estimators in terms of efficiency. Additionally, we demonstrate the potential to attain the semiparametric efficiency lower bound when the propensity score admits some special structures, echoing the insight of Hahn (1998).
Biometrika Longitudinal Data Testing & Uncertainty · 发表于 2024-06-14
T Guédon, C Baey, E Kuhn
摘要
Summary: We examine the problem of variance component testing in general mixed effects models using the likelihood ratio test. We account for the presence of nuisance parameters, ie, the fact that some untested variances might also be equal to zero. Two main issues arise in this context, leading to a nonregular setting. First, under the null hypothesis, the true parameter value lies on the boundary of the parameter space. Moreover, due to the presence of nuisance parameters, the exact locations of these boundary points are not known, which prevents the use of classical asymptotic theory of maximum likelihood estimation. Then, in the specific context of nonlinear mixed effects models, the Fisher information matrix is singular at the true parameter value. We address these two points by proposing a shrunk parametric bootstrap procedure, which is straightforward to apply even for nonlinear models. We show that the procedure is consistent, solving both the boundary and the singularity issues, and we provide a verifiable criterion for the applicability of our theoretical results. We show through a simulation study that, compared to the asymptotic approach, our procedure has a better small sample performance and is more robust to the presence of nuisance parameters. A real data application on bird growth rates is also provided.
JASA Other · 发表于 2024-06-13
Ameer Dharamshi, Anna Neufeld, Keshav Motwani, Lucy L. Gao, Daniela Witten, Jacob Bien
摘要
Our goal is to develop a general strategy to decompose a random variable X into multiple independent random variables, without sacrificing any information about unknown parameters. A recent paper showed that for some well-known natural exponential families, X can be thinned into independent random variables X ( 1 ) , … , X ( K ) , such that X = ∑ k = 1 K X ( k ) . These independent random variables can then be used for various model validation and inference tasks, including in contexts where traditional sample splitting fails. In this paper, we generalize their procedure by relaxing this summation requirement and simply asking that some known function of the independent random variables exactly reconstruct X . This generalization of the procedure serves two purposes. First, it greatly expands the families of distributions for which thinning can be performed. Second, it unifies sample splitting and data thinning, which on the surface seem to be very different, as applications of the same principle. This shared principle is sufficiency. We use this insight to perform generalized thinning operations for a diverse set of families. *(abstract via PubMed)*
SMMR High-Dimensional · 发表于 2024-06-12
Yilei Ma, Youpeng Su, Peng Wang, Ping Yin
摘要
Estimation of the 100 p percent lethal dose ([Formula: see text]) is of great interest to pharmacologists for assessing the toxicity of certain compounds. However, most existing literature focuses on the interval estimation of [Formula: see text] and little attention has been paid to its point estimation. Currently, the most commonly used method for estimating the [Formula: see text] is the maximum likelihood estimator (MLE), which can be represented as a ratio estimator, with the denominator being the slope estimated from the logistic regression model. However, the MLE can be seriously biased when the sample size is small, a common nature in such studies, or when the dose–response curve is relatively flat (i.e. the slope approaches zero). In this study, we address these issues by developing a novel penalised maximum likelihood estimator (PMLE) that can prevent the denominator of the ratio from being close to zero. Similar to the MLE, the PMLE is computationally simple and thus can be conveniently used in practice. Moreover, with a suitable penalty parameter, we show that the PMLE can (a) reduce the bias to the second order with respect to the sample size and (b) avoid extreme estimates. Through simulation studies and real data applications, we show that the PMLE generally outperforms the existing methods in terms of bias and root mean square error.
JASA Causal Inference · 发表于 2024-06-12
Jing Qin, Yukun Liu, Moming Li, Chiung-Yu Huang
摘要
Owing to its appealing distribution-free feature, conformal inference has become a popular tool for constructing prediction intervals with a desired coverage rate. In scenarios involving covariate shift, where the shift function needs to be estimated from data, many existing methods resort to data-splitting techniques. However, these approaches often lead to wider intervals and less reliable coverage rates, especially when dealing with finite sample sizes. To address these challenges, we propose methods based on a pivotal quantity derived under a parametric working model and employ a resampling-based framework to approximate its distribution. The resampling-based approach can produce prediction intervals with a desired coverage rate without splitting the data and can be easily applied to causal inference settings where a shift in the covariate distribution can occur between treatment and control arms. Additionally, the proposed approaches enjoy a double robustness property and are adaptable to different prediction tasks. Our extensive numerical experiments demonstrate that, compared to existing methods, the proposed novel approaches can produce substantially shorter conformal prediction intervals with lower variability in the interval lengths while maintaining promising coverage rates and advantages in versatile usage. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*
JASA Machine Learning Latent Variables & Mixtures · 发表于 2024-06-11
Elynn Y. Chen, Rui Song, Michael I. Jordan
摘要
Reinforcement Learning holds great promise for data-driven decision-making in various social contexts, including healthcare, education, and business. However, classical methods that focus on the mean of the total return may yield misleading results when dealing with heterogeneous populations typically found in large-scale datasets. To address this issue, we introduce the K-Value Heterogeneous Markov Decision Process, a framework designed to handle sequential decision problems with latent population heterogeneity. Within this framework, we propose auto-clustered policy evaluation for estimating the value of a given policy and auto-clustered policy iteration for estimating the optimal policy within a parametric policy class. Our auto-clustered algorithms can automatically identify homogeneous subpopulations while simultaneously estimating the action value function and the optimal policy for each subgroup. We establish convergence rates and construct confidence intervals for the estimators. Simulation results support our theoretical findings, and an empirical study conducted on a real medical dataset confirms the presence of value heterogeneity and validates the advantages of our novel approach. *(abstract via OpenAlex)*
SiM Diagnostics & Prediction · 发表于 2024-06-11
Mohsen Sadatsafavi, John Petkau
摘要
Moderate calibration, the expected event probability among observations with predicted probability z being equal to z, is a desired property of risk prediction models. Current graphical and numerical techniques for evaluating moderate calibration of risk prediction models are mostly based on smoothing or grouping the data. As well, there is no widely accepted inferential method for the null hypothesis that a model is moderately calibrated. In this work, we discuss recently‐developed, and propose novel, methods for the assessment of moderate calibration for binary responses. The methods are based on the limiting distributions of functions of standardized partial sums of prediction errors converging to the corresponding laws of Brownian motion. The novel method relies on well‐known properties of the Brownian bridge which enables joint inference on mean and moderate calibration, leading to a unified “bridge” test for detecting miscalibration. Simulation studies indicate that the bridge test is more powerful, often substantially, than the alternative test. As a case study we consider a prediction model for short‐term mortality after a heart attack, where we provide suggestions on graphical presentation and the interpretation of results. Moderate calibration can be assessed without requiring arbitrary grouping of data or using methods that require tuning of parameters.
Biometrics Diagnostics & Prediction Causal Inference · 发表于 2024-06-11
Lang Li, Anastasia Ivanova
摘要
In many randomized placebo-controlled trials with a biomarker defined subgroup, it is believed that this subgroup has the same or higher treatment effect compared with its complement. These subgroups are often referred to as the biomarker positive and negative subgroups. Most biomarker-stratified pivotal trials are aimed at demonstrating a significant treatment effect either in the biomarker positive subgroup or in the overall population. A major shortcoming of this approach is that the treatment can be declared effective in the overall population even though it has no effect in the biomarker negative subgroup. We use the isotonic assumption about the treatment effects in the two subgroups to construct an efficient way to test for a treatment effect in both the biomarker positive and negative subgroups. A substantial reduction in the required sample size for such a trial compared with existing methods makes evaluating the treatment effect in both the biomarker positive and negative subgroups feasible in pivotal trials especially when the prevalence of the biomarker positive subgroup is less than 0.5.
JASA Bayesian Methods Genetics & Omics · 发表于 2024-06-11
Asher Spector, Lucas Janson
摘要
Scientists often must simultaneously localize and discover signals. For instance, in genetic fine-mapping, high correlations between nearby genetic variants make it hard to identify the exact locations of causal variants. So the statistical task is to output as many disjoint regions containing a signal as possible, each as small as possible, while controlling false positives. Similar problems arise, for example, when locating stars in astronomical surveys and in changepoint detection. Common Bayesian approaches to these problems involve computing a posterior distribution over signal locations. However, existing procedures to translate these posteriors into credible regions for the signals fail to capture all the information in the posterior, leading to lower power and (sometimes) inflated false discoveries. We introduce Bayesian Linear Programming (BLiP), which can efficiently convert any posterior distribution over signals into credible regions for signals. BLiP overcomes an extremely high-dimensional and nonconvex problem to verifiably nearly maximize expected power while controlling false positives. Applying BLiP to existing state-of-the-art analyses of UK Biobank data (for genetic fine-mapping) and the Sloan Digital Sky Survey (for astronomical point source detection) increased power by 30%–120% in just a few minutes of additional computation. BLiP is implemented in pyblip (Python) and blipr (R). Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*
SiM Bayesian Methods Optimization & Learning Theory Clinical Trials · 发表于 2024-06-10
Cheng‐Han Yang, Evan Kwiatkowski, J. Jack Lee, Ruitao Lin
摘要
The rise of cutting‐edge precision cancer treatments has led to a growing significance of the optimal biological dose (OBD) in modern oncology trials. These trials now prioritize the consideration of both toxicity and efficacy simultaneously when determining the most desirable dosage for treatment. Traditional approaches in early‐phase oncology trials have conventionally relied on the assumption of a monotone relationship between treatment efficacy and dosage. However, this assumption may not hold valid for novel oncology therapies. In reality, the dose‐efficacy curve of such treatments may reach a plateau at a specific dose, posing challenges for conventional methods in accurately identifying the OBD. Furthermore, achieving reliable identification of the OBD is typically not possible based on a single small‐sample trial. With data from multiple phase I and phase I/II trials, we propose a novel Bayesian random‐effects dose‐optimization meta‐analysis (REDOMA) approach to identify the OBD by synthesizing toxicity and efficacy data from each trial. The REDOMA method can address trials with heterogeneous characteristics. We adopt a curve‐free approach based on a Gamma process prior to model the average dose‐toxicity relationship. In addition, we utilize a Bayesian model selection framework that uses the spike‐and‐slab prior as an automatic variable selection technique to eliminate monotonic constraints on the dose‐efficacy curve. The good performance of the REDOMA method is confirmed by extensive simulation studies.
SiM Survival Analysis Missing Data & Measurement Error · 发表于 2024-06-10
Chi‐Chung Wen, Yi‐Hau Chen
摘要
Analysis of competing risks data has been an important topic in survival analysis due to the need to account for the dependence among the competing events. Also, event times are often recorded on discrete time scales, rendering the models tailored for discrete‐time nature useful in the practice of survival analysis. In this work, we focus on regression analysis with discrete‐time competing risks data, and consider the errors‐in‐variables issue where the covariates are prone to measurement errors. Viewing the true covariate value as a parameter, we develop the conditional score methods for various discrete‐time competing risks models, including the cause‐specific and subdistribution hazards models that have been popular in competing risks data analysis. The proposed estimators can be implemented by efficient computation algorithms, and the associated large sample theories can be simply obtained. Simulation results show satisfactory finite sample performances, and the application with the competing risks data from the scleroderma lung study reveals the utility of the proposed methods.
SiM Other · 发表于 2024-06-10
Li‐Chun Zhang, Tiziana Tuoto
摘要
Analysis of integrated data often requires record linkage in order to join together the data residing in separate sources. In case linkage errors cannot be avoided, due to the lack a unique identity key that can be used to link the records unequivocally, standard statistical techniques may produce misleading inference if the linked data are treated as if they were true observations. In this paper, we propose methods for categorical data analysis based on linked data that are not prepared by the analyst, such that neither the match‐key variables nor the unlinked records are available. The adjustment is based on the proportion of false links in the linked file and our approach allows the probabilities of correct linkage to vary across the records without requiring that one is able to estimate this probability for each individual record. It accommodates also the general situation where unmatched records that cannot possibly be correctly linked exist in all the sources. The proposed methods are studied by simulation and applied to real data.
SiM Survival Analysis · 发表于 2024-06-09
Henrik F. Thomsen, Nanna L. Lausvig, Christian B. Pipper, Søren Andersen, Lars H. Damgaard, Scott S. Emerson, Henrik Ravn
摘要
We investigate the familywise error rate (FWER) for time‐to‐event endpoints evaluated using a group sequential design with a hierarchical testing procedure for secondary endpoints. We show that, in this setup, the correlation between the log‐rank test statistics at interim and at end of study is not congruent with the canonical correlation derived for normal‐distributed endpoints. We show, both theoretically and by simulation, that the correlation also depends on the level of censoring, the hazard rates of the endpoints, and the hazard ratio. To optimize operating characteristics in this complex scenario, we propose a simulation‐based method to assess the FWER which, better than the alpha‐spending approach, can inform the choice of critical values for testing secondary endpoints.
SiM Longitudinal Data Bayesian Methods Clinical Trials · 发表于 2024-06-09
Maximilian D. Rohde, Benjamin French, Thomas G. Stewart, Frank E. Harrell
摘要
Ordinal longitudinal outcomes are becoming common in clinical research, particularly in the context of COVID‐19 clinical trials. These outcomes are information‐rich and can increase the statistical efficiency of a study when analyzed in a principled manner. We present Bayesian ordinal transition models as a flexible modeling framework to analyze ordinal longitudinal outcomes. We develop the theory from first principles and provide an application using data from the Adaptive COVID‐19 Treatment Trial (ACTT‐1) with code examples in R. We advocate that researchers use ordinal transition models to analyze ordinal longitudinal outcomes when appropriate alongside standard methods such as time‐to‐event modeling.
SiM Bayesian Methods Latent Variables & Mixtures · 发表于 2024-06-09
Jonathan Beall, Hong Li, Bonnie Martin‐Harris, Brian Neelon, Jordan Elm, Evan Graboyes, Elizabeth Hill
摘要
Dysphagia, a common result of other medical conditions, is caused by malfunctions in swallowing physiology resulting in difficulty eating and drinking. The Modified Barium Swallow Study (MBSS), the most commonly used diagnostic tool for evaluating dysphagia, can be assessed using the Modified Barium Swallow Impairment Profile (MBSImP™). The MBSImP assessment tool consists of a hierarchical grouped data structure with multiple domains, a set of components within each domain which characterize specific swallowing physiologies, and a set of tasks scored on a discrete scale within each component. We lack sophisticated approaches to extract patterns of physiologic swallowing impairment from the MBSImP task scores within a component while still recognizing the nested structure of components within a domain. We propose a Bayesian hierarchical profile regression model, which uses a Bayesian profile regression model in conjunction with a hierarchical Dirichlet process mixture model to (1) cluster subjects into impairment profile patterns while respecting the hierarchical grouped data structure of the MBSImP, and (2) simultaneously determine associations between latent profile cluster membership for all components and the outcome of dysphagia severity. We apply our approach to a cohort of patients referred for an MBSS and assessed using the MBSImP. Our research results can be used to inform appropriate intervention strategies, and provide tools for clinicians to make better multidimensional management and treatment decisions for patients with dysphagia.
SiM Clinical Trials · 发表于 2024-06-09
Thomas Burnett, Franz König, Thomas Jaki
摘要
Multi‐arm multi‐stage (MAMS) platform trials efficiently compare several treatments with a common control arm. Crucially MAMS designs allow for adjustment for multiplicity if required. If for example, the active treatment arms in a clinical trial relate to different dose levels or different routes of administration of a drug, the strict control of the family‐wise error rate (FWER) is paramount. Suppose a further treatment becomes available, it is desirable to add this to the trial already in progress; to access both the practical and statistical benefits of the MAMS design. In any setting where control of the error rate is required, we must add corresponding hypotheses without compromising the validity of the testing procedure.To strongly control the FWER, MAMS designs use pre‐planned decision rules that determine the recruitment of the next stage of the trial based on the available data. The addition of a treatment arm presents an unplanned change to the design that we must account for in the testing procedure. We demonstrate the use of the conditional error approach to add hypotheses to any testing procedure that strongly controls the FWER. We use this framework to add treatments to a MAMS trial in progress. Simulations illustrate the possible characteristics of such procedures.
SiM High-Dimensional · 发表于 2024-06-07
Morgane Philipp, Adrien Tessier, Mark Donnelly, Lanyan Fang, Kairui Feng, Liang Zhao, Stella Grosser, Guoying Sun, Wanjie Sun, France Mentré, Julie Bertrand
摘要
Conventional pharmacokinetic (PK) bioequivalence (BE) studies aim to compare the rate and extent of drug absorption from a test (T) and reference (R) product using non‐compartmental analysis (NCA) and the two one‐sided test (TOST). Recently published regulatory guidance recommends alternative model‐based (MB) approaches for BE assessment when NCA is challenging, as for long‐acting injectables and products which require sparse PK sampling. However, our previous research on MB‐TOST approaches showed that model misspecification can lead to inflated type I error. The objective of this research was to compare the performance of model selection (MS) on R product arm data and model averaging (MA) from a pool of candidate structural PK models in MBBE studies with sparse sampling. Our simulation study was inspired by a real case BE study using a two‐way crossover design. PK data were simulated using three structural models under the null hypothesis and one model under the alternative hypothesis. MB‐TOST was applied either using each of the five candidate models or following MS and MA with or without the simulated model in the pool. Assuming T and R have the same PK model, our simulation shows that following MS and MA, MB‐TOST controls type I error rates at or below 0.05 and attains similar or even higher power than when using the simulated model. Thus, we propose to use MS prior to MB‐TOST for BE studies with sparse PK sampling and to consider MA when candidate models have similar Akaike information criterion.
SMMR High-Dimensional · 发表于 2024-06-07
Cristian L Bayes, Jorge Luis Bazán, Luis Valdivieso
摘要
Bounded count response data arise naturally in health applications. In general, the well-known beta-binomial regression model form the basis for analyzing this data, specially when we have overdispersed data. Little attention, however, has been given to the literature on the possibility of having extreme observations and overdispersed data. We propose in this work an extension of the beta-binomial regression model, named the beta-2-binomial regression model, which provides a rather flexible approach for fitting a regression model with a wide spectrum of bounded count response data sets under the presence of overdispersion, outliers, or excess of extreme observations. This distribution possesses more skewness and kurtosis than the beta-binomial model but preserves the same mean and variance form of the beta-binomial model. Additional properties of the beta-2-binomial distribution are derived including its behavior on the limits of its parametric space. A penalized maximum likelihood approach is considered to estimate parameters of this model and a residual analysis is included to assess departures from model assumptions as well as to detect outlier observations. Simulation studies, considering the robustness to outliers, are presented confirming that the beta-2-binomial regression model is a better robust alternative, in comparison with the binomial and beta-binomial regression models. We also found that the beta-2-binomial regression model outperformed the binomial and beta-binomial regression models in our applications of predicting liver cancer development in mice and the number of inappropriate days a patient spent in a hospital.
SiM Clinical Trials Survival Analysis Bayesian Methods · 发表于 2024-06-06
Luana Boumendil, Sylvie Chevret, Vincent Lévy, Lucie Biard
摘要
Adaptive randomized clinical trials are of major interest when dealing with a time‐to‐event outcome in a prolonged observation window. No consensus exists either to define stopping boundaries or to combine values or test statistics in the terminal analysis in the case of a frequentist design and sample size adaptation. In a one‐sided setting, we compared three frequentist approaches using stopping boundaries relying on ‐spending functions and a Bayesian monitoring setting with boundaries based on the posterior distribution of the log‐hazard ratio. All designs comprised a single interim analysis with an efficacy stopping rule and the possibility of sample size adaptation at this interim step. Three frequentist approaches were defined based on the terminal analysis: combination of stagewise statistics (Wassmer) or of values (Desseaux), or on patientwise splitting (Jörgens), and we compared the results with those of the Bayesian monitoring approach (Freedman). These different approaches were evaluated in a simulation study and then illustrated on a real dataset from a randomized clinical trial conducted in elderly patients with chronic lymphocytic leukemia. All approaches controlled for the type I error rate, except for the Bayesian monitoring approach, and yielded satisfactory power. It appears that the frequentist approaches are the best in underpowered trials. The power of all the approaches was affected by the violation of the proportional hazards (PH) assumption. For adaptive designs with a survival endpoint and a one‐sided alternative hypothesis, the Wassmer and Jörgens approaches after sample size adaptation should be preferred, unless violation of PH is suspected.
Biometrics Bayesian Methods Networks & Graphs · 发表于 2024-06-06
Chuhsing Kate Hsiao
摘要
This modern introduction to statistical modeling and inference provides beginning students in data sciences and statistics the opportunity to benefit from two schools, the frequentist and Bayesian, in a unified problem-solving manner. Unlike traditional ways of learning frequentist theories first and then Bayesian statistics in a later advanced course, this textbook simultaneously introduces both methodologies to students at the beginning of their studies. Given that many statisticians in the real world embrace and utilize both approaches, this concurrent learning process is practical and relevant. The second distinguishing feature of this book is its inclusion of modern analytical tools commonly used in contemporary data analysis. These tools, such as model assessment, model averaging, regularization in regression, mixture distributions, expectation-maximization (EM) algorithms, Bayesian data augmentation, neural networks, and social networks, are widely employed in scientific communities for modeling purposes. Third, the book incorporates numerous application studies to illustrate the inferential tools. These studies provide concrete examples that enhance the understanding and relevance of the theories behind these tools. The structure and contents are outlined below. While the chapters are not explicitly grouped into specific “parts,” they can be loosely separated, as I have done in the following paragraphs, each of which represents a thematic section. I aim to provide readers with an organized framework while preserving the elements of surprise and discovery as they delve into the content. The first six chapters cover fundamental elements, introducing various studies, research questions, and collected data (in Chapters 3 and 4), which will be used throughout the book. Additionally, the book addresses sample surveys commonly encountered in the real world (Chapter 5) and metrics defined with probabilities (Chapter 6). This chapter on probability discusses the interpretations of relative frequency and degree of belief, laying the groundwork for inference in subsequent chapters. Moreover, the author examines the pitfalls of probability misuse through the tragic case of the Sally Clark trial. The formal introduction to statistical inference begins in Chapter 7. The content is intense. It contains many basic principles in inference, and yet the presentation is easy and exciting to follow. The chapter starts with the highlights of evidence in policymaking. Then, it moves to estimation methods with the survey sampling approach, followed by the introduction of the model-based theories, with emphasis on discrete distributions. The likelihood, frequentist theory, and Bayesian theory are explained in this chapter as well. The rest of this chapter then demonstrates how to apply these two theories and how to interpret the results in various studies. Chapter 8 focuses mainly on analyzing binomial data from randomized clinical trials (RCTs). Again, both frequentist and Bayesian approaches are introduced to be applied in RCTs and the well-known extra-corporeal membrane oxygenation (ECMO) trial is demonstrated. Chapter 9 is a detour for data visualization with histograms, empirical distributions, and survival functions. Inference methods for one-dimensional continuous distributions are considered in Chapter 10 and two-dimensional continuous distributions are covered in Chapter 11. Chapter 10 starts with the exponential distribution, its likelihood function, and derivations of the maximum likelihood estimator (MLE); it then discusses parameter transformation and how it affects the frequentist asymptotic inference but not the Bayesian inference. Inference on the Gaussian model is next investigated, followed by one-parameter frequentist and Bayesian hypothesis testing. Chapter 11 moves to two-parameter continuous distributions, including the Gaussian and three skewed distributions: the lognormal, Weibull, and Gamma. The prior specification (joint prior) and inference (with joint posterior from conditional and marginal posterior distributions) of the two-dimensional parameter are nicely and concisely explained. Chapter 12 assesses the appropriateness of continuous models employed to fit the observed data. The author compares the ordered data with the beta posterior distribution so that multiple fitted models can be evaluated simultaneously and displayed with graphs. The next two chapters, 13 and 14, are unique in textbooks of statistical inference. They contain concise and essential information for modern data scientists. Chapter 13 discusses only the multinomial distribution. The author begins with an explanation of why this chapter is placed after the two-parameter continuous distributions. The beginning of this chapter is very much worth reading. The rest of this chapter contains a brief discussion of frequentist analysis and a more detailed discussion of the Bayesian analysis. The Dirichlet process prior is introduced in this chapter. Chapter 14 examines the model fit with the likelihood ratio test, Bayes factor, frequentist deviance, and Bayesian deviance, when the models are nested and non-nested. This chapter contains many tools considered in model evaluation and concludes with a discussion of model choice and model averaging, making it a good source for students new to this field. Chapters 15–18 are about regression models. Chapter 15 contains most elements one can find in a standard regression textbook, including the design of covariates, interaction terms, and even regularization (ridge, lasso, and elastic net) regression and principal component regression. Chapter 16 discusses incompleteness and missingness, and this chapter then focuses on mixture distributions, EM algorithms, Bayesian analysis, and data augmentation. Many applications are demonstrated to exemplify the analytical tools, so that readers can repeat the analysis by themselves. Chapter 17 is about generalized linear models (GLMs). The theoretical derivations behind GLMs are only briefly explained but many examples are given for demonstrations. Extensions of GLMs are introduced in Chapter 18. Polynomial, piecewise regression, and networks are discussed here. Examples are used to illustrate these extensions with publicly available data, so anyone can recreate the plots and results stated in the book. There are two topics I would love to read about, but are not covered. The first one concerns multivariate data inference, particularly visualization strategies to explore potential relationships among multivariate data that could offer clues in formulating complex models. I understand, however, that this could significantly burden the already heavy volume. Although several related models and analyses, including regularization regression, principal components, and networks, have been discussed in different chapters, a section specifically devoted to this topic, along with other inference methods, could be considered. In addition, it would be nice to read the author’s presentation of the generalized linear mixed effects model (GLMMs) as a new section in Chapter 18 in a future edition. Overall, the book has many features that are personal favorites of mine: a lot of applications that illustrate the methods, a good combination of likelihood and model-based approaches, inclusion of computational operations on methods, and a parallel demonstration of frequentist and Bayesian analyses. Additionally, Appendix 4 provides a short history of statistics from 1890 by introducing four statisticians (Karl Pearson, Ronald Fisher, Jerzy Neyman, and Harold Jeffreys) and describing how they influenced the modern statistics society. This book can be used as a course textbook or for self-learning. Readers can acquire a general understanding of statistical inference and be prepared for any further advanced materials. I highly recommend this book to students who want to pursue a career in data science and statistics. Finally, I want to repeat the final sentence of the Preface: “Bayesians are a diverse group.” This is inspiring. I believe all statisticians are—and have to be—a diverse group, to foster and advance the scientific community. *(abstract via OpenAlex)*
SMMR Survival Analysis Diagnostics & Prediction Nonparametric & Semiparametric · 发表于 2024-06-06
Wei Liu, Danping Liu, Zhiwei Zhang
摘要
Prognostic biomarkers for survival outcomes are widely used in clinical research and practice. Such biomarkers are often evaluated using a C-index as well as quantities based on time-dependent receiver operating characteristic curves. Existing methods for their evaluation generally assume that censoring is uninformative in the sense that the censoring time is independent of the failure time with or without conditioning on the biomarker under evaluation. With focus on the C-index and the area under a particular receiver operating characteristic curve, we describe and compare three estimation methods that account for informative censoring based on observed baseline covariates. Two of them are straightforward extensions of existing plug-in and inverse probability weighting methods for uninformative censoring. By appealing to semiparametric theory, we also develop a doubly robust, locally efficient method that is more robust than the plug-in and inverse probability weighting methods and typically more efficient than the inverse probability weighting method. The methods are evaluated and compared in a simulation study, and applied to real data from studies of breast cancer and heart failure.
SiM Optimization & Learning Theory Clinical Trials · 发表于 2024-06-06
Yuhan Li, Yiding Zhang, Gu Mi, Ji Lin
摘要
The US FDA's Project Optimus initiative that emphasizes dose optimization prior to marketing approval represents a pivotal shift in oncology drug development. It has a ripple effect for rethinking what changes may be made to conventional pivotal trial designs to incorporate a dose optimization component. Aligned with this initiative, we propose a novel seamless phase II/III design with dose optimization (SDDO framework). The proposed design starts with dose optimization in a randomized setting, leading to an interim analysis focused on optimal dose selection, trial continuation decisions, and sample size re‐estimation (SSR). Based on the decision at interim analysis, patient enrollment continues for both the selected dose arm and control arm, and the significance of treatment effects will be determined at final analysis. The SDDO framework offers increased flexibility and cost‐efficiency through sample size adjustment, while stringently controlling the Type I error. This proposed design also facilitates both accelerated approval (AA) and regular approval in a “one‐trial” approach. Extensive simulation studies confirm that our design reliably identifies the optimal dosage and makes preferable decisions with a reduced sample size while retaining statistical power.
Biometrics Testing & Uncertainty · 发表于 2024-06-05
Jacob Fiksel
摘要
Randomization-based inference using the Fisher randomization test allows for the computation of Fisher-exact P-values, making it an attractive option for the analysis of small, randomized experiments with non-normal outcomes. Two common test statistics used to perform Fisher randomization tests are the difference-in-means between the treatment and control groups and the covariate-adjusted version of the difference-in-means using analysis of covariance. Modern computing allows for fast computation of the Fisher-exact P-value, but confidence intervals have typically been obtained by inverting the Fisher randomization test over a range of possible effect sizes. The test inversion procedure is computationally expensive, limiting the usage of randomization-based inference in applied work. A recent paper by Zhu and Liu developed a closed form expression for the randomization-based confidence interval using the difference-in-means statistic. We develop an important extension of Zhu and Liu to obtain a closed form expression for the randomization-based covariate-adjusted confidence interval and give practitioners a sufficiency condition that can be checked using observed data and that guarantees that these confidence intervals have correct coverage. Simulations show that our procedure generates randomization-based covariate-adjusted confidence intervals that are robust to non-normality and that can be calculated in nearly the same time as it takes to calculate the Fisher-exact P-value, thus removing the computational barrier to performing randomization-based inference when adjusting for covariates. We also demonstrate our method on a re-analysis of phase I clinical trial data.
Biometrics Causal Inference Nonparametric & Semiparametric · 发表于 2024-06-05
Xueqing Liu, Tianchen Qian, Lauren Bell, Bibhas Chakraborty
摘要
In mobile health, tailoring interventions for real-time delivery is of paramount importance. Micro-randomized trials have emerged as the “gold-standard” methodology for developing such interventions. Analyzing data from these trials provides insights into the efficacy of interventions and the potential moderation by specific covariates. The “causal excursion effect,” a novel class of causal estimand, addresses these inquiries. Yet, existing research mainly focuses on continuous or binary data, leaving count data largely unexplored. The current work is motivated by the Drink Less micro-randomized trial from the UK, which focuses on a zero-inflated proximal outcome, i.e., the number of screen views in the subsequent hour following the intervention decision point. To be specific, we revisit the concept of causal excursion effect, specifically for zero-inflated count outcomes, and introduce novel estimation approaches that incorporate nonparametric techniques. Bidirectional asymptotics are established for the proposed estimators. Simulation studies are conducted to evaluate the performance of the proposed methods. As an illustration, we also implement these methods to the Drink Less trial data.
SMMR Survival Analysis Clinical Trials · 发表于 2024-06-05
Jean Marie Boher, Thomas Filleron, Patrick Sfumato, Pierre Bunouf, Richard J Cook
摘要
Despite the widespread use of Cox regression for modeling treatment effects in clinical trials, in immunotherapy oncology trials and other settings therapeutic benefits are not immediately realized thereby violating the proportional hazards assumption. Weighted logrank tests and the so-called Maxcombo test involving the combination of multiple logrank test statistics have been advocated to increase power for detecting effects in these and other settings where hazards are nonproportional. We describe a testing framework based on supremum logrank statistics created by successively analyzing and excluding early events, or obtained using a moving time window. We then describe how such tests can be conducted in a group sequential trial with interim analyses conducted for potential early stopping of benefit. The crossing boundaries for the interim test statistics are determined using an easy-to-implement Monte Carlo algorithm. Numerical studies illustrate the good frequency properties of the proposed group sequential methods.
SiM Bayesian Methods · 发表于 2024-06-05
Keisuke Tada, Kazushi Maruo, Masahiko Gosho
摘要
Due to the insufficiency of safety assessments of clinical trials for drugs, further assessments are required for post‐marketed drugs. In addition to adverse drug reactions (ADRs) induced by one drug, drug‐drug interaction (DDI)‐induced ADR should also be investigated. The spontaneous reporting system (SRS) is a powerful tool for evaluating the safety of drugs continually. In this study, we propose a novel Bayesian method for detecting potential DDIs in a database collected by the SRS. By applying a power prior, the proposed method can borrow information from similar drugs for a drug assessed DDI to increase sensitivity of detection. The proposed method can also adjust the amount of the information borrowed by tuning the parameters in power prior. In the simulation study, we demonstrate the aforementioned increase in sensitivity. Depending on the scenarios, approximately 20 points of sensitivity of the proposed method increase from an existing method to a maximum. We also indicate the possibility of early detection of potential DDIs by the proposed method through analysis of the database shared by the Food and Drug Administration. In conclusion, the proposed method has a higher sensitivity and a novel criterion to detect potential DDIs early, provided similar drugs have similar observed‐expected ratios to the drug under assessment.
SiM Clinical Trials Longitudinal Data · 发表于 2024-06-04
Emily C. Voldal, Avi Kenny, Fan Xia, Patrick Heagerty, James P. Hughes
摘要
Stepped wedge trials (SWTs) are a type of cluster randomized trial that involve repeated measures on clusters and design‐induced confounding between time and treatment. Although mixed models are commonly used to analyze SWTs, they are susceptible to misspecification particularly for cluster‐longitudinal designs such as SWTs. Mixed model estimation leverages both “horizontal” or within‐cluster information and “vertical” or between‐cluster information. To use horizontal information in a mixed model, both the mean model and correlation structure must be correctly specified or accounted for, since time is confounded with treatment and measurements are likely correlated within clusters. Alternative non‐parametric methods have been proposed that use only vertical information; these are more robust because between‐cluster comparisons in a SWT preserve randomization, but these non‐parametric methods are not very efficient. We propose a composite likelihood method that focuses on vertical information, but has the flexibility to recover efficiency by using additional horizontal information. We compare the properties and performance of various methods, using simulations based on COVID‐19 data and a demonstration of application to the LIRE trial. We found that a vertical composite likelihood model that leverages baseline data is more robust than traditional methods, and more efficient than methods that use only vertical information. We hope that these results demonstrate the potential value of model‐based vertical methods for SWTs with a large number of clusters, and that these new tools are useful to researchers who are concerned about misspecification of traditional models.